• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Uremic Peripheral Neuropathy in Nondiabetic Chronic Hemodialysis Patients.非糖尿病慢性血液透析患者的尿毒症周围神经病变
Ann Indian Acad Neurol. 2025 Jul 1;28(4):590-593. doi: 10.4103/aian.aian_74_25. Epub 2025 Jun 28.
2
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.抗抑郁药治疗成人慢性疼痛的疼痛管理:一项网络荟萃分析。
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.
3
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
4
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
5
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
6
The clinical effectiveness and cost-effectiveness of enzyme replacement therapy for Gaucher's disease: a systematic review.戈谢病酶替代疗法的临床疗效和成本效益:一项系统评价。
Health Technol Assess. 2006 Jul;10(24):iii-iv, ix-136. doi: 10.3310/hta10240.
7
Topical capsaicin (high concentration) for chronic neuropathic pain in adults.局部用辣椒素(高浓度)治疗成人慢性神经性疼痛。
Cochrane Database Syst Rev. 2017 Jan 13;1(1):CD007393. doi: 10.1002/14651858.CD007393.pub4.
8
Topical clonidine for neuropathic pain in adults.局部用可乐定治疗成人神经病理性疼痛。
Cochrane Database Syst Rev. 2022 May 19;5(5):CD010967. doi: 10.1002/14651858.CD010967.pub3.
9
Tramadol for neuropathic pain in adults.曲马多用于成人神经性疼痛。
Cochrane Database Syst Rev. 2017 Jun 15;6(6):CD003726. doi: 10.1002/14651858.CD003726.pub4.
10
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.

本文引用的文献

1
Correlation between nerve conduction changes and BETA-2 microglobulin concentration in chronic kidney disease patients on hemodialysis combined with hemodiafiltration online.在线血液透析滤过联合血液透析的慢性肾脏病患者神经传导变化与β2-微球蛋白浓度的相关性。
Medicine (Baltimore). 2023 Feb 17;102(7):e32978. doi: 10.1097/MD.0000000000032978.
2
Peripheral Neuropathy in Children With Chronic Kidney Disease: Are We Looking Enough?慢性肾脏病患儿的周围神经病变:我们的关注足够了吗?
Ann Indian Acad Neurol. 2022 May-Jun;25(3):389-393. doi: 10.4103/aian.aian_1067_21. Epub 2022 Jun 24.
3
Epidemiology of chronic kidney disease: an update 2022.慢性肾脏病流行病学:2022年最新情况
Kidney Int Suppl (2011). 2022 Apr;12(1):7-11. doi: 10.1016/j.kisu.2021.11.003. Epub 2022 Mar 18.
4
Pain Assessment in Hemodialysis Patients.血液透析患者的疼痛评估
Cureus. 2020 Feb 6;12(2):e6903. doi: 10.7759/cureus.6903.
5
Uremic neuropathy: an overview of the current literature.尿毒症神经病变:当前文献综述
Rev Assoc Med Bras (1992). 2019 Mar;65(3):469-474. doi: 10.1590/1806-9282.65.3.469. Epub 2019 Apr 11.
6
Expression and significance of CD4(+)CD25(+)CD127(-) regulatory T cells in peripheral blood of patients with different phenotypes of Guillain-Barré syndrome.不同表型吉兰-巴雷综合征患者外周血中CD4(+)CD25(+)CD127(-)调节性T细胞的表达及意义
Int J Clin Exp Med. 2015 Oct 15;8(10):19126-31. eCollection 2015.
7
The prevalence of peripheral neuropathy in hemodialysis patients.血液透析患者周围神经病变的患病率。
Clin Nephrol. 2012 Jun;77(6):468-75. doi: 10.5414/cn107188.
8
Distal nerve excitability and conduction studies in a case of rapidly regressive acute motor neuropathy with multiple motor conduction blocks.一例伴有多处运动传导阻滞的快速退行性急性运动神经病患者的远端神经兴奋性和传导研究
J Peripher Nerv Syst. 2010 Dec;15(4):369-72. doi: 10.1111/j.1529-8027.2010.00285.x.
9
[Neurological complications in uremia].[尿毒症中的神经系统并发症]
Acta Neurol Taiwan. 2008 Jun;17(2):117-26.
10
Peripheral neuropathy in type 2 diabetes mellitus in Isfahan, Iran: prevalence and risk factors.伊朗伊斯法罕2型糖尿病患者的周围神经病变:患病率及危险因素
Acta Neurol Scand. 2006 Dec;114(6):384-91. doi: 10.1111/j.1600-0404.2006.00716.x.

非糖尿病慢性血液透析患者的尿毒症周围神经病变

Uremic Peripheral Neuropathy in Nondiabetic Chronic Hemodialysis Patients.

作者信息

Aatif Taoufiq, Labioui Narjiss, Laasli Hajjar, Zajjari Yassir, Kabbaj Driss El

机构信息

Department of Nephrology Dialysis and Renal Transplantation, Mohammed V Military Hospital, UM5, Rabat, Morocco.

出版信息

Ann Indian Acad Neurol. 2025 Jul 1;28(4):590-593. doi: 10.4103/aian.aian_74_25. Epub 2025 Jun 28.

DOI:10.4103/aian.aian_74_25
PMID:40580435
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12393846/
Abstract

Chronic kidney disease is a global public health problem. Emphasis has been placed on uremic peripheral neuropathy (PN) in nondiabetic chronic hemodialysis (HD) patients. This complication could affect the quality of life. We aimed to determine the prevalence and risk factors of PN. This was a cross-sectional study. Evaluation of PN was made by clinical examination and electroneuromyogram. The prevalence of PN was 30.3%. The most common symptoms were paresthesia and burning. Neuropathic pain was symmetrical in the majority of cases and localized to the lower limb (60%). All patients had axonal type PN. In univariate analysis, the risk factors for PN were advanced age ( P = 0.012), hypertension ( P = 0.007), ischemic heart disease ( P = 0.036), high C-reactive protein (microinflammation) ( P = 0.002), low urea reduction ratio ( P = 0.013), and high ß2 microglobulin ( P = 0.002). Since PN is common in nondiabetic chronic HD patients, it becomes necessary to diagnose it and correct its risk factors.

摘要

慢性肾脏病是一个全球性的公共卫生问题。非糖尿病慢性血液透析(HD)患者的尿毒症周围神经病变(PN)已受到关注。这种并发症会影响生活质量。我们旨在确定PN的患病率及危险因素。这是一项横断面研究。通过临床检查和神经电生理检查对PN进行评估。PN的患病率为30.3%。最常见的症状是感觉异常和烧灼感。在大多数病例中,神经病理性疼痛是对称的,且多局限于下肢(60%)。所有患者均为轴索性PN。单因素分析显示,PN的危险因素包括高龄(P = 0.012)、高血压(P = 0.007)、缺血性心脏病(P = 0.036)、高C反应蛋白(微炎症)(P = 0.002)、低尿素清除率(P = 0.013)和高β2微球蛋白(P = 0.002)。由于PN在非糖尿病慢性HD患者中很常见,因此有必要对其进行诊断并纠正其危险因素。